UTMD's Q2 earnings per share decline 10.1% year over year, while quarterly revenues face pressure from lost customers and slower new business growth.
UTMD reports a year-over-year decline in Q1 earnings per share and sales, pressured by lost distributor business and higher costs, despite improved margins and a strong balance sheet.
UTMD's niche leadership, global footprint, and strong cash generation position it to benefit from rising demand for high-quality maternal and neonatal healthcare solutions.
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Kevin L. Cornwell CEO | XSTU Exchange | US9174881089 ISIN |
| US Country | 146 Employees | 17 Sep 2026 Last Dividend | 22 Mar 1993 Last Split | 8 Mar 1999 IPO Date |
Utah Medical Products, Inc. specializes in the development, manufacture, and distribution of medical devices for the healthcare sector. Founded in 1978, the company targets a variety of essential areas within the medical field, including fetal monitoring, labor and delivery, neonatal care, gynecology, and urology, among others. Serving neonatal intensive care units, labor and delivery departments, and women’s health centers in hospitals, as well as outpatient clinics and physician's offices, Utah Medical Products, Inc. has established a comprehensive distribution network. This network spans direct customer service and sales forces, independent consultants, and manufacturers' representatives, ensuring their wide array of medical devices is accessible to healthcare providers. Headquartered in Midvale, Utah, the company is committed to innovation in medical devices to improve patient care and treatment outcomes.